Interdisciplinary Health Research Team in Musculoskeletal Neoplasia, Canada

Registration Status: Completed

Objective: Interdisciplinary Health Research Team (IHRT) in Musculoskeletal (MSK) Neoplasia is the result of a unique collaboration between clinicians and basic scientists who represent a comprehensive cross-section of geographic and professional constituencies. The health issues under investigation in the application are the pathogenesis, treatment and treatment-related morbidity of primary malignant tumours (sarcomas) of the bones and soft tissues and the benign lesions that are often associated with sarcoma. These diseases affect up to 2% of Canadians1 and represent an important health issue.

Registered Biobank Name Interdisciplinary Health Research Team in Musculoskeletal Neoplasia
Biobank Leader Co-Investigators: Dr. Jay Wunder, Dr. Rita Kandel, Dr. Irene Andrulis, Dr. Aileen Davis, Dr. Richard Hill, Dr. David Malkin, Dr. Ben Alman; Associate: Dr. Robert Turcotte, Dr. Bas Masri, Dr. Brian O’Sullivan, Dr. Joel Werier, Dr. Marc Isler
Country Canada
Email for biobank inquiries anthony.bozzo.med@ssss.gouv.qc.ca
Principal Investigator Dr. Robert S. Bell, Department of Surgery, Mount Sinai Hospital
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: